ReviewNano convergence2026
Simulation-guided design of peptide-metal coordination interfaces for next-generation metallo-immunotherapy.
Review in Nano convergence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapeutic Metal Ions: Engineering Biomaterials for Multimodal Disease Treatment.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Metal ions are crucial regulators of immune signaling, metabolism, and redox homeostasis, but their therapeutic deployment in cancer immunotherapy is limited by systemic toxicity and inadequate spatiotemporal control. Peptide–metal coordination interfaces offer a programmable solution by combining sequence-encoded recognition with tunable coordination chemistry, enabling controlled metal speciation, bioavailability, and stimulus-responsive functions in complex biological environments. This review summarizes how biologically relevant ions, including Mn2+, Zn2+, Cu2+, and Fe2+/Fe3+, modulate innate and adaptive immunity through direct reprogramming of macrophages, dendritic cells, T cells, and natural killer cells, as well as through indirect remodeling of the tumor microenvironment via immunogenic cell death, redox perturbation, hypoxia alleviation, and disruption of immunosuppressive pathways. We discuss essential peptide–metal coordination principles, including natural binding motifs, synthetic coordination primitives, and stimulus-responsive switching mechanisms that enable dynamic regulation of metal–ligand interactions. To accelerate rational discovery, we outline a simulation-guided computational toolbox integrating docking-based prescreening, molecular dynamics, and metadynamics for stability assessment, quantum mechanical/molecular mechanics approaches for electronic-level accuracy, and machine learning workflows for multi-parameter optimization across high-dimensional design spaces. Finally, we survey the application landscape of peptide–metal platforms, from self-assembled ion-reservoir architectures to hybrid systems incorporating lipidic, polymeric, inorganic, or biomimetic carriers for improved pharmacokinetics and combinatorial functionality. Collectively, this perspective connects coordination chemistry with immunoengineering and highlights simulation-guided strategies for designing adaptive metallo-immunotherapeutic nanoplatforms with spatiotemporal precision and translational potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.